-
Je něco špatně v tomto záznamu ?
DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis - A narrative review from the ECNP bipolar disorders network
LV. Kessing, A. González-Pinto, A. Fagiolini, A. Bechdolf, A. Reif, A. Yildiz, B. Etain, C. Henry, E. Severus, EZ. Reininghaus, G. Morken, GM. Goodwin, J. Scott, JR. Geddes, M. Rietschel, M. Landén, M. Manchia, M. Bauer, M....
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- bipolární porucha * diagnóza epidemiologie MeSH
- Diagnostický a statistický manuál mentálních poruch MeSH
- lidé MeSH
- mezinárodní klasifikace nemocí MeSH
- opožděná diagnóza MeSH
- prevalence MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
This narrative review summarizes and discusses the implications of the Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 and the upcoming International Classification of Diseases (ICD)-11 classification systems on the prevalence of bipolar disorder and on the validity of the DSM-5 diagnosis of bipolar disorder according to the Robin and Guze criteria of diagnostic validity. Here we review and discuss current data on the prevalence of bipolar disorder diagnosed according to DSM-5 versus DSM-IV, and data on characteristics of bipolar disorder in the two diagnostic systems in relation to extended Robin and Guze criteria: 1) clinical presentation, 2) associations with para-clinical data such as brain imaging and blood-based biomarkers, 3) delimitation from other disorders, 4) associations with family history / genetics, 5) prognosis and long-term follow-up, and 6) treatment effects. The review highlights that few studies have investigated consequences for the prevalence of the diagnosis of bipolar disorder and for the validity of the diagnosis. Findings from these studies suggest a substantial decrease in the point prevalence of a diagnosis of bipolar with DSM-5 compared with DSM-IV, ranging from 30-50%, but a smaller decrease in the prevalence during lifetime, corresponding to a 6% reduction. It is concluded that it is likely that the use of DSM-5 and ICD-11 will result in diagnostic delay and delayed early intervention in bipolar disorder. Finally, we recommend areas for future research.
Aalborg University Hospital Psychiatry Aalborg Denmark
Department of Clinical Medicine Aalborg University Aalborg Denmark
Department of Mental Health and Sensory Organs University of Siena School of Medicine Siena Italy
Department of Pharmacology Dalhousie University Halifax NS Canada
Department of Psychiatry Amsterdam UMC Vrije Universiteit Amsterdam the Netherlands
Department of Psychiatry and Neurochemistry University of Gothenburg Gothenburg Sweden
Department of Psychiatry and Psychotherapeutic Medicine Medical University of Graz Graz Austria
Department of Psychiatry BIOARABA Hospital Universitario de Alava UPV EHU CIBERSAM Vitoria Spain
Department of Psychiatry Dalhousie University Halifax NS Canada
Department of Psychiatry Dokuz Eylül University İzmir Turkey
Department of Psychiatry Erasmus Medical Center Rotterdam the Netherlands
Institute of Neuroscience Newcastle University Newcastle United Kingdom
Institute of Psychiatric Phenomics and Genomics University Hospital LMU Munich Germany
National Institute of Mental Health Klecany Czech Republic
Psychology Clinic of East Anglia 68 Bishopgate NR1 4AA Norwich United Kingdom
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22019701
- 003
- CZ-PrNML
- 005
- 20220804135920.0
- 007
- ta
- 008
- 220720s2021 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.euroneuro.2021.01.097 $2 doi
- 035 __
- $a (PubMed)33541809
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Kessing, Lars Vedel $u Copenhagen Affective Disorder research Centre (CADIC), Psychiatric Centre Copenhagen, Department O, University Hospital of Copenhagen, Rigshospitalet, and University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark. Electronic address: lars.vedel.kessing@regionh.dk
- 245 10
- $a DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis - A narrative review from the ECNP bipolar disorders network / $c LV. Kessing, A. González-Pinto, A. Fagiolini, A. Bechdolf, A. Reif, A. Yildiz, B. Etain, C. Henry, E. Severus, EZ. Reininghaus, G. Morken, GM. Goodwin, J. Scott, JR. Geddes, M. Rietschel, M. Landén, M. Manchia, M. Bauer, M. Martinez-Cengotitabengoa, OA. Andreassen, P. Ritter, R. Kupka, RW. Licht, RE. Nielsen, TG. Schulze, T. Hajek, TV. Lagerberg, V. Bergink, E. Vieta
- 520 9_
- $a This narrative review summarizes and discusses the implications of the Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 and the upcoming International Classification of Diseases (ICD)-11 classification systems on the prevalence of bipolar disorder and on the validity of the DSM-5 diagnosis of bipolar disorder according to the Robin and Guze criteria of diagnostic validity. Here we review and discuss current data on the prevalence of bipolar disorder diagnosed according to DSM-5 versus DSM-IV, and data on characteristics of bipolar disorder in the two diagnostic systems in relation to extended Robin and Guze criteria: 1) clinical presentation, 2) associations with para-clinical data such as brain imaging and blood-based biomarkers, 3) delimitation from other disorders, 4) associations with family history / genetics, 5) prognosis and long-term follow-up, and 6) treatment effects. The review highlights that few studies have investigated consequences for the prevalence of the diagnosis of bipolar disorder and for the validity of the diagnosis. Findings from these studies suggest a substantial decrease in the point prevalence of a diagnosis of bipolar with DSM-5 compared with DSM-IV, ranging from 30-50%, but a smaller decrease in the prevalence during lifetime, corresponding to a 6% reduction. It is concluded that it is likely that the use of DSM-5 and ICD-11 will result in diagnostic delay and delayed early intervention in bipolar disorder. Finally, we recommend areas for future research.
- 650 12
- $a bipolární porucha $x diagnóza $x epidemiologie $7 D001714
- 650 _2
- $a opožděná diagnóza $7 D057210
- 650 _2
- $a Diagnostický a statistický manuál mentálních poruch $7 D039721
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mezinárodní klasifikace nemocí $7 D038801
- 650 _2
- $a prevalence $7 D015995
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a González-Pinto, Ana $u Department of Psychiatry, BIOARABA, Hospital Universitario de Alava, UPV/EHU. CIBERSAM, Vitoria, Spain
- 700 1_
- $a Fagiolini, Andrea $u Department of Mental Health and Sensory Organs, University of Siena School of Medicine, Siena, Italy
- 700 1_
- $a Bechdolf, Andreas $u Department of Psychiatry, Psychotherapy and Psychosomatics, Vivantes Hospital am Urban and Vivantes Hospital im Friedrichshain/Charite Medicine Berlin and University of Cologne, Germany
- 700 1_
- $a Reif, Andreas $u Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main, Germany
- 700 1_
- $a Yildiz, Ayşegül $u Department of Psychiatry, Dokuz Eylül University, İzmir, Turkey
- 700 1_
- $a Etain, Bruno $u Université de Paris and INSERM UMRS 1144, Paris, France
- 700 1_
- $a Henry, Chantal $u Department of Psychiatry, Service Hospitalo-Universitaire, GHU Paris Psychiatrie & Neuroscience, Paris, France
- 700 1_
- $a Severus, Emanuel $u Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany
- 700 1_
- $a Reininghaus, Eva Z $u Department of Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria
- 700 1_
- $a Morken, Gunnar $u Department of Psychiatry, St Olav University Hospital & Department of Mental Health, Norwegian University of Science and Technology - NTNU, Trondheim, Norway
- 700 1_
- $a Goodwin, Guy M $u Department of Psychiatry, University of Oxford and Oxford Health NHS Foundation Trust, Oxford, United Kingdom
- 700 1_
- $a Scott, Jan $u Institute of Neuroscience, Newcastle University, Newcastle, United Kingdom
- 700 1_
- $a Geddes, John R $u Department of Psychiatry, University of Oxford and Oxford Health NHS Foundation Trust, Oxford, United Kingdom
- 700 1_
- $a Rietschel, Marcella $u Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
- 700 1_
- $a Landén, Mikael $u Department of Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg, Sweden
- 700 1_
- $a Manchia, Mirko $u Section of Psychiatry, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italia; Department of Pharmacology, Dalhousie University, Halifax, NS, Canada
- 700 1_
- $a Bauer, Michael $u Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany
- 700 1_
- $a Martinez-Cengotitabengoa, Monica $u Osakidetza, Basque Health Service. Bioaraba, Health Research Institute, University of the Basque Country, UPV/EHU, Spain; Psychology Clinic of East Anglia. 68 Bishopgate, NR1 4AA, Norwich, United Kingdom
- 700 1_
- $a Andreassen, Ole A $u NORMENT Centre, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- 700 1_
- $a Ritter, Philipp $u Department of Psychiatry, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany
- 700 1_
- $a Kupka, Ralph $u Department of Psychiatry, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands
- 700 1_
- $a Licht, Rasmus W $u Aalborg University Hospital, Psychiatry, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
- 700 1_
- $a Nielsen, René Ernst $u Aalborg University Hospital, Psychiatry, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
- 700 1_
- $a Schulze, Thomas G $u Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Germany
- 700 1_
- $a Hajek, Tomas $u Department of Psychiatry, Dalhousie University, Halifax, NS, Canada; National Institute of Mental Health, Klecany, Czech Republic
- 700 1_
- $a Lagerberg, Trine Vik $u NORMENT Centre, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- 700 1_
- $a Bergink, Veerle $u Department of Psychiatry and Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine and Mount Sinai, New York, USA; Department of Psychiatry, Erasmus Medical Center, Rotterdam, the Netherlands
- 700 1_
- $a Vieta, Eduard $u Bipolar and Depressive Disorders Unit, Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain
- 773 0_
- $w MED00001656 $t European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology $x 1873-7862 $g Roč. 47, č. - (2021), s. 54-61
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33541809 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804135913 $b ABA008
- 999 __
- $a ok $b bmc $g 1823062 $s 1170944
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 47 $c - $d 54-61 $e 20210202 $i 1873-7862 $m European neuropsychopharmacology $n Eur Neuropsychopharmacol $x MED00001656
- LZP __
- $a Pubmed-20220720
